Department Of Infectious Disease
Investigator
Magdalena Sobieszczyk, MD
Phone
212-305-7185
Email
mes52@cumc.columbia.edu
Dr. Magdalena Sobieszczyk is the Harold Neu Professor of Infectious Diseases (in Medicine) at the Columbia University Medical Center. She is the Chief of Infectious Diseases at the Columbia University Irving Medical Center in New York. Dr. Sobieszczyk is a clinical virologist and the principal investigator of the NIH-funded Columbia Collaborative Clinical Trials Unit which has been advancing the science of HIV and emerging infections like SARS-CoV-2.
Clinical Studies Managed By This Investigator:
Condition Study Title
HIV [ CLOSED ] A phase 1/2a HIV vaccine study designed to test the safety and immune responses of different vaccine combinations among HIV adults.
HIV HIV Prevention Study
Healthy Volunteers HIV Prevention Study
Healthy Volunteers [ CLOSED ] Antibodies for HIV Prevention
HIV [ CLOSED ] Antibodies against HIV
Healthy Volunteers [ CLOSED ] HIV prevention study: HVTN 120
Healthy Volunteers [ CLOSED ] Bispecific Antibody Study: 18-60-year-old, Healthy & HIV-Negative Volunteers
HIV [ CLOSED ] Bispecific Antibody Study for 18-60-year-old People Who Live With HIV/AIDS
Healthy Volunteers [ CLOSED ] HIV Vaccine Study Among 18-60 year-old Sexually Active Men or Transgender Individuals
Healthy Volunteers [ CLOSED ] A Study Among 18-50 Year Old People Who Do NOT Have HIV Comparing an Antibody in Combination with 3 Different Antibodies (CUIMC)
COVID-19 (Coronavirus) [ CLOSED ] Study of Sarilumab for Patients Hospitalized with COVID-19
COVID-19 (Coronavirus) ARMOR Study: A Study to Follow COVID-19 Antibodies Over Time
COVID-19 (Coronavirus) [ CLOSED ] A study to describe immune responses in study participants with a history of infection with SARS-CoV-2, the virus that causes COVID-19
COVID-19 (Coronavirus) Screening for COVID-19 Vaccine, Prevention and Treatment Research Studies
Healthy Volunteers [ CLOSED ] HVTN 302: HIV Vaccine Trial for Healthy, HIV Negative Adults, Ages 18-55
HIV Stick2PrEP: Women/Trans/Non-Binary Individuals
COVID-19 (Coronavirus) COVID-19 Treatment Study: ACTIV-2d/A5407
Infectious Disease Respiratory Syncytial Virus (RSV) Vaccine Study
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE